Mesoporous silica nanoparticles in medicine--recent advances.
暂无分享,去创建一个
Cecilia Sahlgren | M. Lindén | C. Sahlgren | Veronika Mamaeva | V. Mamaeva | Mika Lindén | Veronika Mamaeva
[1] Taeghwan Hyeon,et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. , 2008, Angewandte Chemie.
[2] Bengt Fadeel,et al. Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells. , 2009, Toxicology and applied pharmacology.
[3] R. Lockey,et al. Cationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivo. , 2004, Journal of nanoscience and nanotechnology.
[4] F. Xiao,et al. pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery , 2005 .
[5] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[6] Christy L. Haynes,et al. Functional assessment of metal oxide nanoparticle toxicity in immune cells. , 2010, ACS nano.
[7] Huang-Hao Yang,et al. An efficient cell-targeting and intracellular controlled-release drug delivery system based on MSN-PEM-aptamer conjugates , 2009 .
[8] Hongchen Gu,et al. The packaging of siRNA within the mesoporous structure of silica nanoparticles. , 2011, Biomaterials.
[9] Hamidreza Ghandehari,et al. Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold. , 2012, ACS nano.
[10] M. Maynadier,et al. Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors. , 2011, Angewandte Chemie.
[11] Mauro Ferrari,et al. Enabling individualized therapy through nanotechnology. , 2010, Pharmacological research.
[12] Soyoung Lee,et al. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. , 2011, Biomaterials.
[13] Avelino Corma,et al. Monodispersed mesoporous silica nanoparticles with very large pores for enhanced adsorption and release of DNA. , 2009, The journal of physical chemistry. B.
[14] Minhong Yan,et al. Chronic DLL4 blockade induces vascular neoplasms , 2010, Nature.
[15] Tian Xia,et al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. , 2011, ACS nano.
[16] Srikanth K. Iyer,et al. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. , 2011, The Journal of clinical investigation.
[17] Y. Hung,et al. Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells , 2009 .
[18] Bice Fubini,et al. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. , 2003, Free radical biology & medicine.
[19] Ramón Martínez-Máñez,et al. Toward the development of ionically controlled nanoscopic molecular gates. , 2004, Journal of the American Chemical Society.
[20] S. Artavanis-Tsakonas,et al. Notch signaling: cell fate control and signal integration in development. , 1999, Science.
[21] Xinglu Huang,et al. The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species. , 2010, Biomaterials.
[22] Victor S-Y Lin,et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. , 2003, Journal of the American Chemical Society.
[23] Elena Aznar,et al. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides". , 2010, ACS nano.
[24] Cecilia Sahlgren,et al. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges. , 2010, Nanoscale.
[25] Dominique Lison,et al. The nanosilica hazard: another variable entity , 2010, Particle and Fibre Toxicology.
[26] Z. Su,et al. Uniform hollow mesoporous silica nanocages for drug delivery in vitro and in vivo for liver cancer therapy , 2011 .
[27] Iseult Lynch,et al. Protein-nanoparticle interactions: What does the cell see? , 2009, Nature nanotechnology.
[28] Dong Chen,et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. , 2011, ACS nano.
[29] E Ingham,et al. Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness. , 2011, Nature nanotechnology.
[30] V. S. Lin,et al. Real-Time Imaging of Tunable Adenosine 5-Triphosphate Release from an MCM-41-Type Mesoporous Silica Nanosphere-Based Delivery System , 2005, Applied spectroscopy.
[31] J. S. Beck,et al. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism , 1992, Nature.
[32] Thijs J. Hagenbeek,et al. Therapeutic antibody targeting of individual Notch receptors , 2010, Nature.
[33] Gang Wang,et al. Accelerated oxidation of epinephrine by silica nanoparticles. , 2009, Langmuir : the ACS journal of surfaces and colloids.
[34] Minbo Lan,et al. Nano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.
[35] Chung-Yuan Mou,et al. Multifunctional Mesoporous Silica Nanoparticles for Intracellular Labeling and Animal Magnetic Resonance Imaging Studies , 2008, Chembiochem : a European journal of chemical biology.
[36] Min Zhang,et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. , 2009, Small.
[37] E. Anderson. Hudson et al. , 1977 .
[38] R. Martínez‐Máñez,et al. pH- and photo-switched release of guest molecules from mesoporous silica supports. , 2009, Journal of the American Chemical Society.
[39] K. Tsutsumi,et al. Novel pathways for the preparation of mesoporous MCM-41 materials: control of porosity and morphology , 1999 .
[40] Michael J. Sailor,et al. Chitosan Hydrogel‐Capped Porous SiO2 as a pH Responsive Nano‐Valve for Triggered Release of Insulin , 2009 .
[41] I. Kwon,et al. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery , 2010, Nanotechnology.
[42] Yuhan Sun,et al. pH-Responsive Drug Release from Polymer-Coated Mesoporous Silica Spheres , 2009 .
[43] K. Martin,et al. The chemistry of silica and its potential health benefits. , 2007, The journal of nutrition, health & aging.
[44] Hans Clevers,et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells , 2005, Nature.
[45] Saji George,et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. , 2009, ACS nano.
[46] Manuel Arruebo,et al. Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates. , 2008, Small.
[47] L. J. Mueller,et al. pH-responsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker. , 2010, Journal of the American Chemical Society.
[48] K. Kuroda,et al. The preparation of alkyltrimethylammonium-kanemite complexes and their conversion to microporous materials. , 1990 .
[49] Zongxi Li,et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. , 2010, ACS nano.
[50] S. Bensamoun,et al. Accelerated Achilles tendon healing by PDGF gene delivery with mesoporous silica nanoparticles. , 2010, Biomaterials.
[51] Hyesung Jeon,et al. Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery. , 2011, ACS nano.
[52] G. Fryxell,et al. IN VITRO AND IN VIVO EVALUATION OF A NOVEL FERROCYANIDE FUNCTIONALIZED NANOPOUROUS SILICA DECORPORATION AGENT FOR CESIUM IN RATS , 2010, Health physics.
[53] T. Minko,et al. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA , 2011, Journal of drug targeting.
[54] Dong Chen,et al. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. , 2010, ACS nano.
[55] Erkki Ruoslahti,et al. Targeting of drugs and nanoparticles to tumors , 2010, The Journal of cell biology.
[56] R. Martínez‐Máñez,et al. Controlled release using mesoporous materials containing gate-like scaffoldings , 2009, Expert opinion on drug delivery.
[57] C Jeffrey Brinker,et al. Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery. , 2009, Journal of the American Chemical Society.
[58] Mauro Ferrari,et al. Sustained small interfering RNA delivery by mesoporous silicon particles. , 2010, Cancer research.
[59] H. Lage. An overview of cancer multidrug resistance: a still unsolved problem , 2008, Cellular and Molecular Life Sciences.
[60] Y. Yoshioka,et al. The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1beta production, ROS production and endosomal rupture. , 2010, Biomaterials.
[61] Juan L. Vivero-Escoto,et al. Mesoporous silica nanoparticles for intracellular controlled drug delivery. , 2010, Small.
[62] Y. Lai,et al. Enhanced Chemotherapy of Cancer Using pH-Sensitive Mesoporous Silica Nanoparticles to Antagonize P-Glycoprotein–Mediated Drug Resistance , 2011, Molecular Cancer Therapeutics.
[63] Neetu Singh,et al. Nanoparticles that communicate in vivo to amplify tumour targeting. , 2011, Nature materials.
[64] Bengt Fadeel,et al. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. , 2010, Advanced drug delivery reviews.
[65] R. Hamilton,et al. Silica binding and toxicity in alveolar macrophages. , 2008, Free radical biology & medicine.
[66] Bingyun Li,et al. Nanomedicine as an emerging approach against intracellular pathogens , 2011, International journal of nanomedicine.
[67] J. Zink,et al. In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[68] Eun-Jung Park,et al. Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. , 2009, Toxicology letters.
[69] Cecilia Sahlgren,et al. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. , 2011, Current drug targets.
[70] J. Barrett,et al. Dendritic cell internalization of foam-structured fluorescent mesoporous silica nanoparticles. , 2011, Journal of colloid and interface science.
[71] Chin-Tu Chen,et al. Near‐Infrared Mesoporous Silica Nanoparticles for Optical Imaging: Characterization and In Vivo Biodistribution , 2009 .
[72] Yuen A. Lau,et al. Mechanised nanoparticles for drug delivery. , 2009, Nanoscale.
[73] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[74] G. Hunninghake,et al. Silica directly increases permeability of alveolar epithelial cells. , 1990, Journal of applied physiology.
[75] L. C. Armstrong,et al. Silica increases cytosolic free calcium ion concentration of alveolar macrophages in vitro. , 1991, Toxicology and applied pharmacology.
[76] Toshiro Hirai,et al. Amorphous nanosilica induce endocytosis-dependent ROS generation and DNA damage in human keratinocytes , 2011, Particle and Fibre Toxicology.
[77] Maria Strømme,et al. Mesoporous silica particles induce size dependent effects on human dendritic cells. , 2007, Nano letters.
[78] M. Fujiwara,et al. Switching catalytic reaction conducted in pore void of mesoporous material by redox gate control. , 2006, Chemical communications.
[79] T. Xia,et al. Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.
[80] Raymond E. Moellering,et al. Direct inhibition of the NOTCH transcription factor complex , 2010, Nature.
[81] Cecilia Sahlgren,et al. Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[82] Yaping Li,et al. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. , 2011, Small.
[83] E. Merisko-Liversidge,et al. Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds , 2008, Toxicologic pathology.
[84] K. Hidajat,et al. pH-Controllable drug release using hydrogel encapsulated mesoporous silica. , 2007, Chemical communications.
[85] Tao Wu,et al. Tunable redox-responsive hybrid nanogated ensembles. , 2008, Journal of the American Chemical Society.
[86] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[87] YanagisawaTsuneo,et al. The Preparation of Alkyltriinethylaininonium–Kaneinite Complexes and Their Conversion to Microporous Materials , 2006 .
[88] Chin-Tu Chen,et al. Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. , 2010, Biomaterials.
[89] Kenneth A. Dawson,et al. Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. , 2011, Nature nanotechnology.
[90] V. S. Lin,et al. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. , 2007, Nature nanotechnology.
[91] Erkki Ruoslahti,et al. Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles , 2012, Advanced materials.
[92] M. Maynadier,et al. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy. , 2012, International journal of pharmaceutics.
[93] Taeghwan Hyeon,et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. , 2010, Journal of the American Chemical Society.
[94] Juan L. Vivero-Escoto,et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.
[95] A. Meijer,et al. Mesoporous silica nanoparticles as a compound delivery system in zebrafish embryos , 2012, International journal of nanomedicine.
[96] Antonino Giovia,et al. Labeling and exocytosis of secretory compartments in RBL mastocytes by polystyrene and mesoporous silica nanoparticles , 2012, International journal of nanomedicine.
[97] J. B. Higgins,et al. A new family of mesoporous molecular sieves prepared with liquid crystal templates , 1992 .
[98] K. Neoh,et al. Mesoporous silica nanoparticle-functionalized poly(methyl methacrylate)-based bone cement for effective antibiotics delivery , 2011, Journal of materials science. Materials in medicine.
[99] X. Ji,et al. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. , 2011, Biomaterials.
[100] Iseult Lynch,et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.
[101] Laurence Raehm,et al. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT. , 2012, International journal of pharmaceutics.
[102] H. Gu,et al. Adsorption and desorption behaviors of DNA with magnetic mesoporous silica nanoparticles. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[103] Jeremy L. Steinbacher,et al. Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy , 2011, International journal of cancer.
[104] Xinglu Huang,et al. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. , 2011, Biomaterials.
[105] Victor S-Y Lin,et al. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. , 2005, Angewandte Chemie.
[106] Jeffrey I. Zink,et al. Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles , 2012, Antimicrobial Agents and Chemotherapy.
[107] Jenny Andersson,et al. Influences of Material Characteristics on Ibuprofen Drug Loading and Release Profiles from Ordered Micro- and Mesoporous Silica Matrices , 2004 .
[108] Robert Langer,et al. The biocompatibility of mesoporous silicates. , 2008, Biomaterials.
[109] J. Rosenholm,et al. Cancer-cell targeting and cell-specific delivery by mesoporous silica nanoparticles , 2010 .
[110] L. T. Zhuravlev. The surface chemistry of amorphous silica. Zhuravlev model , 2000 .
[111] H. Santos,et al. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[112] Chunhua Yan,et al. Triple-functional core-shell structured upconversion luminescent nanoparticles covalently grafted with photosensitizer for luminescent, magnetic resonance imaging and photodynamic therapy in vitro. , 2012, Nanoscale.
[113] Stephen Mann,et al. Nanoparticles can cause DNA damage across a cellular barrier. , 2009, Nature nanotechnology.
[114] Erkki Ruoslahti,et al. Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.
[115] Duane E. Prasuhn,et al. The controlled display of biomolecules on nanoparticles: a challenge suited to bioorthogonal chemistry. , 2011, Bioconjugate chemistry.
[116] E. Stachowiak,et al. Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[117] Zongxi Li,et al. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. , 2010, Small.
[118] Matthias Ernst,et al. Cancer research: past, present and future , 2011, Nature Reviews Cancer.
[119] C. C. Landry,et al. Adsorption of DNA into mesoporous silica. , 2006, The journal of physical chemistry. B.
[120] T. Guilarte,et al. Silica-Based Nanoparticle Uptake and Cellular Response by Primary Microglia , 2009, Environmental health perspectives.